Redefining the therapy of severe lung diseases
RNhale has raised $2.6M in total funding. The most recent round was Seed. The last funding was announced in January 2025.
RNhale's investors include European Innovation Council.
RNhale is headquartered in Planegg, Germany.
Redefining the therapy of severe lung diseases
RNhale is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"RNhale — Funding & Investors." VCBacked, January 1, 2025, https://www.vcbacked.co/company/rnhale. Accessed July 20, 2026.
VCBacked. (2025). RNhale — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/rnhale
{{cite web |title=RNhale — Funding & Investors |url=https://www.vcbacked.co/company/rnhale |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated